Delayed granulocyte colony-stimulating factor treatment promotes functional recovery in rats with severe contusive spinal cord injury

Spine

Volumn 37, Issue 1, 2012, Pages 10-17

  Lee, Jung Shun ^a   Yang, Cheng Chang ^a   Kuo, Yu Min ^a,b   Sze, Chun I ^a,b   Hsu, Jung Yu C ^b   Huang, Yi Hung ^c   Tzeng, Shun Fen ^a   Tsai, Ching Lin ^d   Chen, Hsing Hong ^e   Jou, I Ming ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^d LOTUNG POH AI HOSPITAL   (Taiwan)

^e NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

granulocyte colony stimulating factor; severe contusive spinal cord injury; subacute stage

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; MYELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BASSO BEATTIE BRESNAHAN SCALE; CELL INFILTRATION; CONTROLLED STUDY; CONTUSION; CONVALESCENCE; DEMYELINATION; DISEASE SEVERITY; ELECTRON MICROSCOPY; ELECTROPHYSIOLOGY; EVALUATION; EVOKED SOMATOSENSORY RESPONSE; FEMALE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MICROGLIA; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; NONMYELINATED NERVE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RAT; RATING SCALE; SPINAL CORD INJURY; THERAPY DELAY;

ANIMALS; CONTUSIONS; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, SOMATOSENSORY; EXPLORATORY BEHAVIOR; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; LOCOMOTION; MACROPHAGES; MICROGLIA; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES; TIME FACTORS;

EID: 84655175041     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e31823b0440     Document Type: Article

References (44)

1. Kwon BK , Fisher CG , Dvorak MF , et al. Strategies to promote neural repair and regeneration after spinal cord injury. Spine 2005; 30 ( suppl ): S3-13. (Pubitemid 41292197)
2. Sayer FT , Kronvall E , Nilsson OG. Methylprednisolone treatment in acute spinal cord injury: the myth challenged through a structured analysis of published literature. Spine J 2006; 6; 335-43.
3. Hurlbert RJ. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 2000; 93 ( suppl ): 1-7.
4. Suberviola B , González-Castro A , Llorca J , et al. Early complications of high-dose methylprednisolone in acute spinal cord injury patients. Injury 2008; 39; 748-52.
5. Pinzon A , Marcillo A , Quintana A , et al. A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model. Brain Res 2008; 1243; 146-51.
6. Koda M , Nishio Y , Kamada T , et al. Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compressioninduced spinal cord injury in mice. Brain Res 2007; 1149; 223-31. (Pubitemid 46659901)
7. Huang X , Kim JM , Kong TH , et al. GM-CSF inhibits glial scar formation and shows long-term protective effect after spinal cord injury. J Neurol Sci 2009; 277; 87-97.
8. Schneider A , Krüger C , Steigleder T , et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 2005; 115; 2083-98. (Pubitemid 41134150)
9. Solaroglu I , Cahill J , Jadhav V , et al. A novel neuroprotectant granulocyte- colony stimulating factor. Stroke 2006; 37; 1123-8.
10. Malipiero UV , Frei K , Fontana A. Production of hemopoietic colony-stimulating factors by astrocytes. J Immunol 1990; 144; 3816-21. (Pubitemid 20171191)
11. Xiao BG , Lu CZ , Link H. Cell biology and clinical promise of GCSF: immunomodulation and neuroprotection. J Cell Mol Med 2007; 11; 1272-90.
12. Möhle R , Kanz L. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion. Semin Hematol 2007; 44; 193-202. (Pubitemid 47031228)
13. Tigue CC , McKoy JM , Evens AM , et al. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant 2007; 40; 185-92. (Pubitemid 47108460)
14. Orlic D , Kajstura J , Chimenti S , et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001; 98; 10344-9. (Pubitemid 32803022)
15. Stratos I , Rotter R , Eipel C , et al. Granulocyte-colony stimulating factor enhances muscle proliferation and strength following skeletal muscle injury in rats. J Appl Physiol 2007; 103; 1857-63. (Pubitemid 350033874)
16. Tsai KJ , Tsai YC , Shen CK. G-CSF rescues the memory impairment of animal models of Alzheimer s disease. J Exp Med 2007; 204; 1273-80.
17. Pan HC , Chen CJ , Cheng FC , et al. Combination of G-CSF administration and human amniotic fl uid mesenchymal stem cell transplantation promotes peripheral nerve regeneration. Neurochem Res 2009; 34; 1304-16.
18. Shyu WC , Lin SZ , Yang HI , et al. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 2004; 110; 1847-54.
19. Minnerup J , Heidrich J , Wellmann J , et al. Meta-analysis of the effi cacy of granulocyte-colony stimulating factor in animal models of focal cerebral ischemia. Stroke 2008; 39; 1855-61.
20. Shyu WC , Lin SZ , Lee CC , et al. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ 2006; 174; 927-33.
21. Gruner JA. A monitored contusion model of spinal cord injury in the rat. J Neurotrauma 1992; 9; 123-6.
22. Yu SM , Schwartz IR. An improved fl at embedding technique for immunoelectron microscopy. Stain Technol 1989; 64; 143-6. (Pubitemid 20176983)
23. Urdzíková L , Jendelová P , Glogarová K , et al. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma 2006; 23; 1379-91. (Pubitemid 46489623)
24. Barone FC , Feuerstein GZ. Infl ammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 1999; 19; 819-34. (Pubitemid 30173383)
25. Dirnagl U , Iadecola C , Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22; 391-7. (Pubitemid 29453643)
26. Lee ST , Chu K , Jung KH , et al. Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res 2005; 1058; 120-8. (Pubitemid 41416806)
27. Park HK , Chu K , Lee ST , et al. Granulocyte colony-stimulating factor induces sensorimotor recovery in intracerebral hemorrhage. Brain Res 2005; 1041; 125-31.
28. Popovich PG , Wei P , Stokes BT. Cellular infl ammatory response after spinal cord injury in Sprague Dawley and Lewis rats. J Comp Neurol 1997; 377; 443-64. (Pubitemid 27016650)
29. Bresnahan JC , King JS , Martin GF , et al. A neuroanatomical analysis of spinal cord injury in the rhesus monkey ( Macaca mulatta ). J Neurol Sci 1976; 28; 521-42.
30. Rosenberg LJ , Zai LJ , Wrathall JR. Chronic alterations in the cellular composition of spinal cord white matter following contusion injury. Glia 2005; 49; 107-20. (Pubitemid 40023657)
31. Popovich PG , Guan Z , Wei P , et al. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroana- tomical repair after experimental spinal cord injury. Exp Neurol 1999; 58; 351-65. (Pubitemid 29382826)
32. Cittelly DM , Nesic O , Johnson K. Detrimental effects of antiapoptotic treatments in spinal cord injury. Exp Neurol 2008; 210; 295-307.
33. Profyris C , Cheema SS , Zang D , et al. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis 2004; 15; 415-36. (Pubitemid 38429958)
34. Imai M , Watanabe M , Suyama K , et al. Delayed accumulation of activated macrophages and inhibition of remyelination after spinal cord injury in an adult rodent model. J Neurosurg Spine 2008; 8; 58-66.
35. Blight AR. Effects of silica on the outcome from experimental spinal cord injury: implication of macrophages in secondary tissue damage. Neuroscience 1994; 60; 263-73. (Pubitemid 24147624)
36. Horn KP , Busch SA , Hawthorne AL , et al. Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. J Neurosci 2008; 28; 9330-41.
37. Busch SA , Horn KP , Silver DJ , et al. Overcoming macrophagemediated axonal dieback following CNS injury. J Neurosci 2009; 29; 9967-76.
38. de Barros Filho TE , Molina AE. Analysis of the sensitivity and reproducibility of the Basso, Beattie, Bresnahan (BBB) scale in Wistar rats. Clinics 2008; 63; 103-8.
39. Eidelberg E , Straehley D , Erspamer R , et al. Relationship between residual hindlimb-assisted locomotion and surviving axons after incomplete spinal cord injuries. Exp Neurol 1977; 56; 312-22. (Pubitemid 8133618)
40. Windle WF , Smart JO , Beers JJ. Residual function after subtotal spinal cord transection in adult cats. Neurology 1958; 8; 518-21.
41. Wrathall JR , Choiniere D , Teng YD. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX. J Neurosci 1994; 14; 6598-607. (Pubitemid 24333080)
42. Dougherty KD , Dreyfus CF , Black IB. Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/ macrophages after spinal cord injury. Neurobiol Dis 2000; 7; 574-85. (Pubitemid 32044283)
43. Bouhy D , Malgrange B , Multon S , et al. Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages. FASEB J 2006; 20; 1239-41.
44. Vavrek R , Girgis J , Tetzlaff W , et al. BDNF promotes connections of corticospinal neurons onto spared descending interneurons in spinal cord injured rats. Brain 2006; 129; 1534-45 (Pubitemid 43999385)